Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab
Phase of Trial: Phase II
Latest Information Update: 10 May 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 05 Dec 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 26 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Aug 2018.